Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding
Open Access
- 25 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Medicine
- Vol. 26 (1), 1-17
- https://doi.org/10.1186/s10020-020-00227-6
Abstract
Circulating high-mobility group box 1 (HMGB1) plays important roles in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Intracellular HMGB1 is critical for the biology of hepatocytes. However, the intracellular role of HMGB1 in hepatocellular steatosis is unknown. Therefore, we aimed to investigate the role of hepatocyte-specific HMGB1 (HC-HMGB1) in development of hepatic steatosis. Wild type (WT) C57BL/6 and HC-HMGB1−/− mice were fed high-fat diet (HFD) or low-fat diet (LFD) for up to 16 weeks. As expected, HMGB1 translocated from nuclear into cytoplasm and released into circulation after HFD treatment. HC-HMGB1 deficiency significantly reduced circulating HMGB1, suggesting that hepatocyte is a major source of circulating HMGB1 during NAFLD. Unexpectedly, HC-HMGB1 deficiency promoted rapid weight gain with enhanced hepatic fat deposition compared with WT at as early as 4 weeks after HFD treatment. Furthermore, there was no difference between WT and HC-HMGB1−/− mice in glucose tolerance, energy expenditure, liver damage or systemic inflammation. Interestingly, hepatic gene expression related to free fatty acid (FFA) β-oxidation was significantly down-regulated in HC-HMGB1−/− mice compared with WT, and endoplasmic reticulum (ER) stress markers were significantly higher in livers of HC-HMGB1−/− mice. In vitro experiments using primary mouse hepatocytes showed absence of HMGB1 increased FFA-induced intracellular lipid accumulation, accompanied by increased ER-stress, significant downregulation of FFA β-oxidation, and reduced oxidative phosphorylation. Our findings suggest that hepatocyte HMGB1 protects against dysregulated lipid metabolism via maintenance of β-oxidation and prevention of ER stress. This represents a novel mechanism for HMGB1-regulation of hepatocellular steatosis, and suggests that stabilizing HMGB1 in hepatocytes may be effective strategies for prevention and treatment of NAFLD.Other Versions
Funding Information
- NIH (R01-GM102146, R35-GM127027, R01-DK102839)
- Natural Science Foundation of Hunan Province of China (2019JJ50844)
This publication has 43 references indexed in Scilit:
- The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in SepsisImmunity, 2018
- The metabolism of lipoprotein (a): an ever-evolving storyJournal of Lipid Research, 2017
- Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat LoadInternational Journal of Molecular Sciences, 2016
- Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat dietNutrition & Diabetes, 2015
- Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver diseaseExpert Review of Molecular Diagnostics, 2014
- FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and SignalingCell Metabolism, 2012
- Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanismJournal of Hepatology, 2009
- HMGB1: Endogenous Danger SignalingMolecular Medicine, 2008
- Free Fatty Acids Induce JNK-dependent Hepatocyte LipoapoptosisOnline Journal of Public Health Informatics, 2006
- Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes.1995